Active — Not RecruitingNot Applicable

ENSAND 2.0 Evaluation in Nigeria

Nigeria1,568 participantsStarted 2025-05-19

Plain-language summary

The Enhancing Access to Safe and Nutritious Diets 2.0 (ENSAND) (2024-2026) project is designed to address the low per capita consumption of vegetables and variety of vegetable consumption in northern Nigeria by working with smallholder farmers to increase production and promoting healthier diets through greater vegetable consumption among farmers and their neighbors. The objective of this evaluation is to assess the effectiveness of GAIN's ENSAND program for increasing the quantity and variety of vegetables consumed by smallholder farmer households participating in the program and neighbor households paired with the farmers. This evaluation will use a quasi-experimental design to assess the impact of GAIN's ENSAND programs on the quantity and diversity of vegetables consumed by smallholder farmers and their neighbors. The evaluation will be guided by the RE-AIM (reach, effectiveness, adoption, implementation, maintenance) framework. RE-AIM is a framework that is useful for evaluating the program impact of multifaceted and multilevel interventions.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Farmer household or neighbor household recruited by ENSAND farmer * Located within an intervention LGA * Farmer must be member who is participating in the ENSAND project * Adult who is ≥ 18 years old * Able to speak English or Hausa * Provide informed consent to participate in the study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Quantity of vegetables consumed

Timeframe: Baseline (April 2025), Endline (April 2026) (1 year)

Variety of vegetables consumed

Timeframe: Baseline (April 2025), Endline (April 2026) (1 year)

Trial details

NCT IDNCT06927661

SponsorRTI International

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-05-31

View on ClinicalTrials.gov More Quantity and Variety of Vegetables Consumed trials